Repository logo
  • English
  • Srpski (lat)
  • Српски
Log In
Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Bulat, P. (6603213855)"

Filter results by typing the first few letters
Now showing 1 - 7 of 7
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Blood and urine cadmium and bioelements profile in nickel-cadmium battery workers in Serbia
    (2009)
    Bulat, Z. Plamenac (24066576300)
    ;
    Đukić-Ćosić, D. (26639264900)
    ;
    Đokić, M. (55831747600)
    ;
    Bulat, P. (6603213855)
    ;
    Matović, V. (6603086233)
    Although cadmium (Cd) is extensively used for nickel-cadmium battery production, few recent reports are available on the effect of this toxic metal on the imbalance of biometals in occupational exposure. The current study was carried out to determine the Cd level and its effect on the content of bioelements: zinc, cooper, magnesium, and iron in blood and urine of workers exposed to Cd during nickel-cadmium battery production. β2-microglobulins (β2-MG), as indicators of kidney damage, were determined in urine. The study group comprised 32 male nickel-cadmium battery workers, and the control group had 15 male construction workers with no history of Cd exposure. Levels of Cd and bioelements were determined in blood and urine by atomic absorption spectrophotometry. Cd concentration in blood of exposed workers was around 10 μg/L and in urine ranged from 1.93 to 8.76 μg/g creatinine (cr). Urine Cd concentration was significantly higher in exposed workers than in the controls, although no statistical difference in β2-MG content was observed in urine between the two groups. Blood Zn and Mg level were significantly reduced and urine Zn level was increased in Cd-exposed group when compared with controls. The mean Cd concentrations in blood and urine did not exceed the recommended reference values of 10 μg/L in blood and 10 μg/g cr in urine. Cd exposure resulted in disturbances of Zn in blood and urine and Mg in blood but had no effect on Cu and Fe content in biological fluids. © 2009, SAGE Publications. All rights reserved.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Blood and urine cadmium and bioelements profile in nickel-cadmium battery workers in Serbia
    (2009)
    Bulat, Z. Plamenac (24066576300)
    ;
    Đukić-Ćosić, D. (26639264900)
    ;
    Đokić, M. (55831747600)
    ;
    Bulat, P. (6603213855)
    ;
    Matović, V. (6603086233)
    Although cadmium (Cd) is extensively used for nickel-cadmium battery production, few recent reports are available on the effect of this toxic metal on the imbalance of biometals in occupational exposure. The current study was carried out to determine the Cd level and its effect on the content of bioelements: zinc, cooper, magnesium, and iron in blood and urine of workers exposed to Cd during nickel-cadmium battery production. β2-microglobulins (β2-MG), as indicators of kidney damage, were determined in urine. The study group comprised 32 male nickel-cadmium battery workers, and the control group had 15 male construction workers with no history of Cd exposure. Levels of Cd and bioelements were determined in blood and urine by atomic absorption spectrophotometry. Cd concentration in blood of exposed workers was around 10 μg/L and in urine ranged from 1.93 to 8.76 μg/g creatinine (cr). Urine Cd concentration was significantly higher in exposed workers than in the controls, although no statistical difference in β2-MG content was observed in urine between the two groups. Blood Zn and Mg level were significantly reduced and urine Zn level was increased in Cd-exposed group when compared with controls. The mean Cd concentrations in blood and urine did not exceed the recommended reference values of 10 μg/L in blood and 10 μg/g cr in urine. Cd exposure resulted in disturbances of Zn in blood and urine and Mg in blood but had no effect on Cu and Fe content in biological fluids. © 2009, SAGE Publications. All rights reserved.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Framework for the strategic and business planning of the Centre - School of Public Health, Belgrade
    (2006)
    Bjegovic, V. (6602428758)
    ;
    Marinkovic, J. (7004611210)
    ;
    Simic, S. (57526929000)
    ;
    Jankovic, S. (7101906308)
    ;
    Sbutega-Milosevic, G. (6507152149)
    ;
    Bulat, P. (6603213855)
    ;
    Laaser, U. (7005289486)
    The science and practice of the New Public Health have a key role in the promotion of people's health and in the reform of the health system. Serbia experienced many social and economic threats to public health during the 1990s when the health infrastructure both for curative and preventive services gradually deteriorated. Existing skills and knowledge of public health professionals are insufficient in virtually all fields of public health activities. The foundation of the Centre - School of Public Health, within the Medical School of Belgrade University has been a precondition for the improvement of professional training in public health. The objectives are described as (1) education of capable experts in the field of public health, (2) improvement of knowledge in the health sciences, (3) health promotion in cooperation with local communities, (4) training of competent researchers in the field of public health and (5) improvement of the process of decision making and policy formulation. The training programme covers five key areas of education in the domain of public health: (1) public health in Europe, (2) epidemiology and biostatistics, (3) health policy and management, (4) health promotion, health education and social sciences and (5) environment and health. In the first year, 27 students were admitted for the Master of Public Health programme and more than 350 participants attended various short courses for continuing education in public health and health management based on applied learning approach. The next developmental steps focus on sustainability of the programmes for continuing education and research and a wider national and international partnership. © Springer-Verlag 2006.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Further studies on delineating thyroid-stimulating hormone (TSH) reference range
    (2011)
    Žrkovic̀, M. (7003498546)
    ;
    Ciri, J. (54583329500)
    ;
    Beleslin, B. (6701355427)
    ;
    Iri, S. (57203225538)
    ;
    Bulat, P. (6603213855)
    ;
    Topalov, D. (7801389703)
    ;
    Trbojevi, B. (54584412400)
    The aim of the study was to evaluate thyroid-stimulating hormone (TSH) concentration in a reference group and to compare it with the TSH in subjects with high probability of thyroid dysfunction. The study population consisted of 852 subjects. The reference group consisting of 316 subjects was obtained by the exclusion of the subjects having thyroid disease, taking thyroid influencing drugs, having increased thyroid peroxidase (TPO) antibodies, or having abnormal thyroid ultrasound. 42 high probability of thyroid dysfunction subjects were defined by the association of increased TPO antibody concentration, changed echogenicity, and changed echosonographic structure of thyroid parenchyma. In the reference group TSH reference range was 0.45mU/l (95% CI 0.390.56mU/l) to 3.43mU/l (95% CI 3.104.22mU/l). To distinguish reference and high probability of thyroid dysfunction group a TSH threshold was calculated. At a threshold value of 3.09mU/l (95% CI 2.933.38mU/l), specificity was 95% and sensitivity 38.1%. Using 2 different approaches to find upper limit of the TSH reference range we obtained similar results. Using reference group only a value of 3.43mU/l was obtained. Using both reference group and subjects with the high probability of thyroid dysfunction we obtained 95% CI for the upper reference limit between 2.93 and 3.38mU/l. Based on these premises, it could be argued that conservative estimate of the TSH upper reference range should be 3.4mU/l for both sexes. © Georg Thieme Verlag KG.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Further studies on delineating thyroid-stimulating hormone (TSH) reference range
    (2011)
    Žrkovic̀, M. (7003498546)
    ;
    Ciri, J. (54583329500)
    ;
    Beleslin, B. (6701355427)
    ;
    Iri, S. (57203225538)
    ;
    Bulat, P. (6603213855)
    ;
    Topalov, D. (7801389703)
    ;
    Trbojevi, B. (54584412400)
    The aim of the study was to evaluate thyroid-stimulating hormone (TSH) concentration in a reference group and to compare it with the TSH in subjects with high probability of thyroid dysfunction. The study population consisted of 852 subjects. The reference group consisting of 316 subjects was obtained by the exclusion of the subjects having thyroid disease, taking thyroid influencing drugs, having increased thyroid peroxidase (TPO) antibodies, or having abnormal thyroid ultrasound. 42 high probability of thyroid dysfunction subjects were defined by the association of increased TPO antibody concentration, changed echogenicity, and changed echosonographic structure of thyroid parenchyma. In the reference group TSH reference range was 0.45mU/l (95% CI 0.390.56mU/l) to 3.43mU/l (95% CI 3.104.22mU/l). To distinguish reference and high probability of thyroid dysfunction group a TSH threshold was calculated. At a threshold value of 3.09mU/l (95% CI 2.933.38mU/l), specificity was 95% and sensitivity 38.1%. Using 2 different approaches to find upper limit of the TSH reference range we obtained similar results. Using reference group only a value of 3.43mU/l was obtained. Using both reference group and subjects with the high probability of thyroid dysfunction we obtained 95% CI for the upper reference limit between 2.93 and 3.38mU/l. Based on these premises, it could be argued that conservative estimate of the TSH upper reference range should be 3.4mU/l for both sexes. © Georg Thieme Verlag KG.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Occupational skin diseases: actual state analysis of patient management pathways in 28 European countries
    (2017)
    Mahler, V. (7003943682)
    ;
    Aalto-Korte, K. (6603947466)
    ;
    Alfonso, J.H. (56481260000)
    ;
    Bakker, J.G. (16070867400)
    ;
    Bauer, A. (7202699090)
    ;
    Bensefa-Colas, L. (15759139900)
    ;
    Boman, A. (7006704874)
    ;
    Bourke, J. (7102278436)
    ;
    Bubaš, M. (14027854300)
    ;
    Bulat, P. (6603213855)
    ;
    Chaloupka, J. (16424430100)
    ;
    Constandt, L. (6507505992)
    ;
    Danielsen, T.E. (6602130523)
    ;
    Darlenski, R. (24340606000)
    ;
    Dugonik, A. (6506246479)
    ;
    Ettler, K. (55949148600)
    ;
    Gimenez-Arnau, A. (24068420100)
    ;
    Gonçalo, M. (7004688306)
    ;
    Johansen, J.D. (55663372900)
    ;
    John, S.M. (24537218600)
    ;
    Kiec-Swierczynska, M. (16688962000)
    ;
    Koch, P. (7202928732)
    ;
    Kohánka, V. (57194637306)
    ;
    Krecisz, B. (55941867400)
    ;
    Larese Filon, F. (57221974776)
    ;
    Ljubojević, S. (55956418900)
    ;
    Macan, J. (7003635852)
    ;
    Marinović, B. (7003552377)
    ;
    Matura, M. (6603610422)
    ;
    Mihatsch, P.W. (57194640115)
    ;
    Mijakoski, D. (16507108400)
    ;
    Minov, J. (9942846400)
    ;
    Pace, J. (7101714142)
    ;
    Pesonen, M. (24400135100)
    ;
    Ramada Rodilla, J.M. (55581284100)
    ;
    Rast, H. (16747719900)
    ;
    Reljic, V. (55895308600)
    ;
    Salavastru, C. (25632984300)
    ;
    Schuster, C. (56563599300)
    ;
    Schuttelaar, M.L. (6602915888)
    ;
    Simon, D. (17535591900)
    ;
    Spiewak, R. (7004004619)
    ;
    Jurakic Tončić, R. (26023306400)
    ;
    Urbanček, S. (35189611200)
    ;
    Valiukevičienė, S. (12766628700)
    ;
    Weinert, P. (57188730913)
    ;
    Wilkinson, M. (35568541300)
    ;
    Uter, W. (7005681849)
    Background: Work-related skin diseases (WSD) are caused or worsened by a professional activity. Occupational skin diseases (OSD) need to fulfil additional legal criteria which differ from country to country. OSD range amongst the five most frequently notified occupational diseases (musculoskeletal diseases, neurologic diseases, lung diseases, diseases of the sensory organs, skin diseases) in Europe. Objective: To retrieve information and compare the current state of national frameworks and pathways to manage patients with occupational skin disease with regard to prevention, diagnosis, treatment and rehabilitation in different European countries. Methods: A questionnaire-based survey of the current situation regarding OSD patient management pathways was carried out with experts on occupational dermatology and/or occupational medicine from 28 European countries contributing to the European Cooperation in Science and Technology (COST) Action TD 1206 (StanDerm) (www.standerm.eu). Results: Besides a national health service or a statutory health insurance, most European member states implemented a second insurance scheme specifically geared at occupational diseases [insurance against occupational risks (synonyms: insurance against work accidents and occupational injuries; statutory social accident insurance)]. Legal standards for the assessment of occupationally triggered diseases with a genetic background differ between different countries, however, in most European member states recognition as OSD is possible. In one-third of the countries UV light-induced tumours can be recognized as OSD under specific conditions. Conclusion: OSD definitions vary between European countries and are not directly comparable, which hampers comparisons between statistics collected in different countries. Awareness of this fact and further efforts for standardization are necessary. © 2017 European Academy of Dermatology and Venereology
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Undergraduate teaching of occupational medicine in European schools of medicine
    (2014)
    Gehanno, J.F. (6602985798)
    ;
    Bulat, P. (6603213855)
    ;
    Martinez-Jarreta, B. (6603777938)
    ;
    Pauncu, E.A. (35278616400)
    ;
    Popescu, F. (14627804100)
    ;
    Smits, P.B.A. (57211980952)
    ;
    Van Dijk, F.J.H. (7003711284)
    ;
    Braeckman, L. (6701743518)
    Purpose: General practitioners play or should play a role in occupational medicine (OM), either in diagnosing occupational diseases or in counseling on return to work. Nevertheless, their training has been reported to be insufficient in most single country studies. Aims: The objectives of this study were to analyze the content and extent of undergraduate teaching of OM in European medical schools. Methods: An e-mail questionnaire survey of the teaching of OM to undergraduates was undertaken from December 2010 to April 2011 in all medical schools and medical faculties listed in 27 European countries (n = 305). Results: Among the 305 universities identified, 135 answered to the questionnaire, giving a response rate of 44 %. The mean number of hours given to formal instruction in occupational medicine to medical undergraduates was 25.5 h. Nevertheless, this number of hours varied widely between countries, but also within countries. Overall, 27 % of medical schools gave their students 10 h of teaching or less, 52 % 20 h or less and 69 % 30 h or less. Whereas occupational diseases and principles of prevention were covered in most schools, disability and return to work were very poorly represented among the topics that were taught to students. Conclusion: Dedicated undergraduate teaching on occupational health or OM in European medical schools is present in most medical schools, usually at a low level, but is very variable between and within countries. Medical schools across Europe are very unequal to provide qualifying doctors education on the topics they will frequently come across in their working lives. © 2013 Springer-Verlag Berlin Heidelberg.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement
  • Send Feedback